BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26429274)

  • 1. Paddle-based rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Dadkhah H; Bhatia SK; Buatti JM; Xu W; Wu X
    Med Phys; 2015 Oct; 42(10):5992-6003. PubMed ID: 26429274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multihelix rotating shield brachytherapy for cervical cancer.
    Dadkhah H; Kim Y; Wu X; Flynn RT
    Med Phys; 2015 Nov; 42(11):6579-88. PubMed ID: 26520749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Wu X
    Med Phys; 2014 Nov; 41(11):111709. PubMed ID: 25370623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Yang W; Wu X
    Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotating-shield brachytherapy for cervical cancer.
    Yang W; Kim Y; Wu X; Song Q; Liu Y; Bhatia SK; Sun W; Flynn RT
    Phys Med Biol; 2013 Jun; 58(11):3931-41. PubMed ID: 23680601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast dose optimization for rotating shield brachytherapy.
    Cho M; Wu X; Dadkhah H; Yi J; Flynn RT; Kim Y; Xu W
    Med Phys; 2017 Oct; 44(10):5384-5392. PubMed ID: 28744870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
    Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
    Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
    Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
    Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid emission angle selection for rotating-shield brachytherapy.
    Liu Y; Flynn RT; Yang W; Kim Y; Bhatia SK; Sun W; Wu X
    Med Phys; 2013 May; 40(5):051720. PubMed ID: 23635268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Rotating Shield Brachytherapy for Prostate Cancer Dose Escalation and Urethral Sparing.
    Adams Q; Hopfensperger KM; Kim Y; Wu X; Xu W; Shukla H; McGee J; Caster JM; Flynn RT
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1543-1550. PubMed ID: 30092333
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Adams Q; Hopfensperger KM; Kim Y; Wu X; Flynn RT
    Med Phys; 2020 Dec; 47(12):6430-6439. PubMed ID: 33051866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial rotating shield brachytherapy for prostate cancer.
    Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
    Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SU-E-T-547: Rotating Shield Brachytherapy (RSBT) for Cervical Cancer.
    Yang W; Kim Y; Liu Y; Wu X; Flynn R
    Med Phys; 2012 Jun; 39(6Part18):3831. PubMed ID: 28518488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SU-E-T-606: Optimal Emission Angle Selection in Rotating Shield Brachytherapy.
    Liu Y; Flynn R; Yang W; Kim Y; Wu X
    Med Phys; 2012 Jun; 39(6Part19):3845. PubMed ID: 28517084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M; Fields EC; Todor DA
    Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point A vs. HR-CTV D
    Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
    Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer.
    Dadkhah H; Hopfensperger KM; Kim Y; Wu X; Flynn RT
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):719-728. PubMed ID: 28843372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
    Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
    Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.